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Efforts to differentiate embryonic stem cells (ESCs) toward
neurons and glia has primarily focused on generating motor
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doi:10.1016/j.scr.2011.12.002to target neural afflictions such as amyotrophic lateral sclero-
sis (ALS), spinal cord injury, and Parkinson's disease. Over the
last few years, studies have emerged exploring the generation
of forebrain interneurons frommouse (m) and human (h) ESCs.
Multiple lines of evidence implicate dysfunction of forebrain
interneurons in the symptomatology of major neuropsychiat-
ric illnesses, including schizophrenia, autism, Tourette dis-
order, bipolar disorder, and epilepsy. This dysfunction
involves distinct subtypes of interneurons, which differ in
their neurochemistry, connectivity, and physiological
characteristics.
There has been a proliferation of differentiation methods
directed at producing putative cortical interneurons from
ESCs. The purpose of this review is to present the progress
made in generating GABAergic cortical interneurons from
ESCs and to outline the implications of this research for
treating neuropsychiatric disease.
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mammalian forebrain
After gastrulation, the region of ectoderm induced to ac-
quire neural character gives rise to the neural plate, an epi-
thelium that subsequently forms the central and most of the
peripheral nervous systems. Following neural plate forma-
tion, cellular movements result in the formation of bilateral
neural folds (O'Rahilly et al., 2006), which flank an interced-
ing neural groove, the first identifiable morphological struc-
ture in the developing nervous system (~E7–8 in mouse,
~E16–18 in humans) (O'Rahilly et al., 2006). The lengthening
neural plate is broader rostrally, where the three major
brain divisions of the brain – prosencephalon, mesencepha-
lon and rhombencephalon – are identifiable. The prosen-
cephalon or forebrain is further subdivided into the
telencephalon and diencephalon (Fig. 1A).
Studies in mice demonstrate that the most rostral end of
the neural plate undergoes extensive proliferation and mor-
phogenetic movements, transforming the telencephalon
into a set of paired vesicles with regionally restrictedFigure 1 Regionalization of the key proliferative zones within th
brain of an ~E12.5 mouse showing the main subdivisions of the for
the left. (B) Coronal hemisection through the telencephalon highligh
tion factors that are implicated in regulating telencephalic patterni
lium, however, the highest expression is found within the pallium.
dorsal-most region of the LGE (hatched lines) (Corbin et al., 2003)
main domains. The interaction between Shh (ventral) and Gli3 (dors
(D) Schematic showing the primary location for precursor cells that
GABA and acetylcholine. Cholinergic neurons of the striatum (Str) a
MGE (patches of dots) with GP cholinergic neurons emerging from the
gration pathways of precursors that populate different telencephalic
the LGE and MGE to the cortex, which occurs perpendicular to the rad
(A–P) and dorsal–ventral (D–V) axis shown. Abbreviations: POa, anterdorsoventral markers including Dlx1/2, Nkx2.1, Gsx2, Lhx6
and Pax6 (~E12–13 in mouse) (Fig. 1B) (Rallu et al.,
2002a). In a combinatorial arrangement, these markers her-
ald the subsequent emergence of discrete proliferative
zones along the dorsoventral axis of the telencephalon
(~E12–14 in mouse) (Fig. 1B). The pallial telencephalon
can be divided into the anterior/lateral neocortex and the
posterior/medial hippocampus, cortical hem and choroid
plexus. Similarly, the pallidal or subpallial telencephalon
gives rise to the preoptic area, medial ganglionic eminence
(MGE), the lateral ganglionic eminence (LGE) and the caudal
ganglionic eminence (CGE) (~E12–14 in mouse) (Fig. 1)
(Hebert and Fishell, 2008; Marin and Rubenstein, 2001; Nat
and Dechant, 2011; Wonders and Anderson, 2006).
Pivotal to initial patterning of the telencephalon is the
transcription factor Foxg1, with specification of the telence-
phalic primordium dictated by the regionalized expression of
this transcription factor (Hebert and Fishell, 2008). Subse-
quent ventral patterning of the telencephalon primarily re-
lies on Shh. Shh is first expressed in the underlying axial
mesoderm (prechordal plate and notochord) before beinge embryonic mouse forebrain. (A) Sagittal section through the
ebrain, the telencephalon and the diencephalon. Anterior is to
ting the approximate expression patterns of selected transcrip-
ng and differentiation. *Gli3 expression extends into the subpal-
**At this developmental age Pax6 expression continues into the
. (C) Telencephalon of an~E12.5 mouse indicating some of the
al) establishes the dorsoventral (D–V) axis in the telencephalon.
generate neurons expressing the neurotransmitters glutamate,
nd the globus pallidus (GP) are also generated from within the
ventral-most domain of the MGE. Also shown are the primary mi-
domains. The tangential migration of progenitor cells from both
ial migration observed within cortical domains. Anterior–posterior
ior preoptic area; Cx, cortex; H, hippocampus.
418 A.L. Goulburn et al.restricted to the ventral territories of the prosencephalon it-
self, specifically the MGE, and the hypothalamus (Liu and
Niswander, 2005; Rallu et al., 2002a). Shh is essential for
normal ventral telencephalic development with the morpho-
gen promoting the emergence of ventral domains by antago-
nizing the dorsalizing effects of the zinc finger protein Gli3
(Fig. 1B) (Hebert and Fishell, 2008). In this signaling path-
way, Shh represses the conversion of Gli3 from the activator
(Gli3) to the repressor isoform (Gli3R) (Hoch et al., 2009;
Sousa and Fishell, 2010). With the Gli3 expression domain
extending into the subpallium, it has been suggested that
it is the ratio between the two Gli3 isoforms that is impor-
tant to dorsoventral telencephalic patterning (Fig. 1B)
(Fotaki et al., 2006).
Partitioning of the dorsal telencephalon centers on the
paired-box transcription factor Pax6. At the neural plate
stage in the mouse, Pax6 expression is observed throughout
the telencephalic anlagen, with later expression restricted
primarily to the dorsal pallium neocortex domain (Pax6 ex-
pression has been shown to extend into the dorsal-most re-
gion of the LGE) (Fig. 1B) (Manuel and Price, 2005; Rossant
and Tam, 2002). Therefore, regionalized expression of Pax6
is important in defining the pallial–subpallial boundary
that divides the ventral cortical primordium from the dorsal
domain of the subpallium (Hebert and Fishell, 2008). (See
(Hebert and Fishell, 2008) for a more detailed review on
the early genetics of telencephalic development).
In mice, the ganglionic eminences (GEs) of the subpallium
are the primary sites from which cortical inhibitory γ amino-
butyric acid (GABA)-ergic interneurons are generated
(Figs. 1C, D). These interneurons undertake a tangential mi-
gration from the ventricular zones of the subpallium before
integrating in the laminar layers of the cortex (Figs. 1C, D)
(Corbin and Butt, 2011; Marin and Rubenstein, 2001). Like-
wise, there is strong evidence to suggest that human inter-
neurons also originate in the ventral telencephalic MGE
(Batista-Brito and Fishell, 2009; Fertuzinhos et al., 2009;
Letinic et al., 2002). However, unlike rodents, primates
may have an additional location of interneuron genesis in
the subventricular zone of the cerebral cortex (Fertuzinhos
et al., 2009; Letinic et al., 2002; Petanjek et al., 2009).
Depending on the scheme of classification, cortical inter-
neurons comprise at least 15 different subtypes (Batista-
Brito and Fishell, 2009; Moore et al., 2010 and see Ascoli et
al., 2008 for a categorization of cortical interneuron sub-
types). GABAergic cortical interneurons critically balance
activity of functioning excitatory glutamatergic projection
neurons in the neocortex; a balance that is necessary for
the proper functioning of neuronal networks (reviewed in
Batista-Brito and Fishell, 2009 and Corbin and Butt, 2011).
Defects in the development and migration of GABAergic in-
terneurons from the GE domains have been implicated in
neuropsychiatric illnesses such as epilepsy, autism and
schizophrenia (Batista-Brito and Fishell, 2009; Levitt et al.,
2004).Neural induction of ESCs
There are two commonly used methods for directed ecto-
derm differentiation of ESCs. The first employs adherent
‘flat-cultures’ in which ESCs are differentiated either onextra cellular matrix-coated surfaces or on neural inducing
cell layers, while in the second protocol, ESCs are differenti-
ated as three-dimensional aggregates, termed embryoid
bodies (EBs) (Fig. 2) (Erceg et al., 2009; Keller, 2005).
Ectodermal flat-culture differentiation systems frequent-
ly use inductive bone marrow-derived stromal cell layers,
such as MS5 (Aubry et al., 2008; Barberi et al., 2003;
Ideguchi et al., 2010) or the calvarial marrow-derived line
PA6 (Fig. 2) (Irioka et al., 2005; Kawasaki et al., 2000;
Watanabe et al., 2005). The neural inducing activity associ-
ated with PA6 cells has been termed ‘stromal cell-derived
inducing activity’ (SDIA) (Kawasaki et al., 2000). Consistent
with established embryological theories concerning neural
induction, initial experiments indicated that SDIA impinged
on BMP signaling, although the exact mechanisms of action
and the molecular identity of SDIA are still unknown
(Kawasaki et al., 2000). Nevertheless, ESC co-culture with
stromal cell lines has derived various neural cell types in-
cluding GABAergic neurons, dopaminergic neurons, spinal
motoneurons and peripheral sensory neurons (reviewed in
Erceg et al., 2009).
The generation of a variety of neural sub-lineages also re-
flects a key limitation of stromal feeder co-culture differen-
tiations. Despite the use of exogenous growth factors to
direct differentiation, control over the inducing activities
of the stromal layer is limited, predisposing the system to
heterogenous differentiation outcomes. In addition, stromal
layers introduce the risk of pathogen transfer between cell
lines, an issue that would need to be addressed prior to the
use of neural derivatives for clinical applications.
Strategies have been developed for directing neural ESC
differentiation in stromal-free media supplemented with
specific growth factors in a time and concentration depen-
dent manner to influence the course of the neural differen-
tiation (reviewed in Erceg et al., 2009; Denham and
Dottori, 2009 and Petros et al., 2011). These procedures
have allowed the generation of a variety of neural lineages
and specific neuronal subtypes, including midbrain dopa-
mine neurons, spinal motor neurons and cortical projection
neurons (Gaspard et al., 2008; Lee et al., 2000; Wichterle
et al., 2002).
Many protocols include the inhibition of BMP, Nodal and
Wnt signaling pathways to achieve neural induction (Fig. 2)
(for review see Gaspard and Vanderhaeghen, 2010). To this
end, signaling inhibitors such as Noggin, Lefty (Lefty1,
Lefty2, or LeftyA) and Dickkopf-1 (Dkk-1) have all been
used to promote ESC differentiation to early neurectodermal
derivatives (Eiraku et al., 2008; Pera et al., 2004; Perrier et
al., 2004; Smith et al., 2008; Verani et al., 2007; Watanabe
et al., 2005; Watanabe et al., 2007). These inhibitors block
mesendoderm formation and permit the adoption of a de-
fault neurectodermal differentiation program. In mESCs,
Kamiya and colleagues have shown that the zinc-finger nu-
clear protein, Zfp521, is an important BMP molecular regula-
tor during early neurectodermal specification (Kamiya et
al., 2011). In addition, recent work suggests that fibroblast
growth factor-2 (FGF2) can also enhance neural induction,
acting at a stage of differentiation akin to primitive ecto-
derm (epiblast) (Cohen et al., 2010). However, it is also im-
portant to bear in mind the species differences that may
exist in the emergence of neuroepithelial/neuroectoderm
(NE) precursors. For example, recent studies by Zhang and
Figure 2 Differentiation of ESCs towards neural lineages. Undifferentiated ESCs can be differentiated with or without the use of a
co-culture stromal layer. Stromal layer free differentiation platforms employ either a flat culture system using various tissue culture
surface coatings or three-dimensional embryoid body (EB) aggregates. Generally, neural induction involves the use of mesendoderm
signaling antagonists/inhibitors in order to transition undifferentiated ESCs towards an anterior neural precursor fate marked by the
expression of genes including Otx2, Nestin and Pax6. Recent studies have indicated that FGF2 may also contribute to neural induc-
tion. Subsequently, these neural precursors can be directed towards regionalized neural cell types using morphogens and growth fac-
tors. For example retinoic acid (RA) has been shown to generate caudal cell types, Wnt genes have been implicated in producing
dorsalized cells, and Shh application has been demonstrated to induce ventral cell phenotypes. For effects of specific growth factors
refer also to recent reviews (Erceg et al., 2009; Gaspard and Vanderhaeghen, 2010).
419Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cellscolleagues revealed a novel role for PAX6 in early human,
but not mouse NE specification (Zhang et al., 2010). Their
study demonstrated that PAX6 was a transcriptional deter-
minant of human NE and that distinct isoforms coordinated
the transition from pluripotency to the NE fate by inhibiting
pluripotent and activating NE expressed genes respectively
(Zhang et al., 2010).
After neural induction, a second series of growth factors
has been used to direct differentiation towards neural sub-
types (Fig. 2). For example, early studies suggested that
continued exposure to FGF favored neuronal differentiation,
while formation of glial cells was promoted by epidermal
growth factor (EGF) and platelet-derived growth factor
(PDGF) (Barberi et al., 2003; Reubinoff et al., 2001). Reubin-
off and colleagues also reported that the extra-cellular ma-
trix components, laminin and fibronectin, influenced the
balance between neuronal or glial differentiation
(Reubinoff et al., 2001). Furthermore, several factors have
been shown to direct ESC-derived neural precursors towards
region specific cell types, including retinoic acid (RA) (cau-
dal, posterior), sonic hedgehog (ventral) and Wnts (dorsal)
(reviewed in Erceg et al., 2009).Despite the success of protocols in initiating neural induc-
tion from ESCs, the large-scale application of these method-
ologies is constrained by the high cost of recombinant
growth factors. Because of this, recent studies have ex-
plored the use of small molecules to induce step-wise transi-
tions from undifferentiated ESCs toward neural cell types
(Ding and Schultz, 2004; Ding et al., 2003). In this context,
Chambers and colleagues demonstrated that hESCs could
be efficiently converted into neural derivatives by employ-
ing a combination of the BMP inhibitor Noggin and the
small molecule Activin signaling antagonist, SB431542
(Chambers et al., 2009). In this system, Noggin and
SB431542 collaborate to block the SMAD signaling required
for mesendoderm formation, thus promoting neural differ-
entiation (Chambers et al., 2009).Generation of cortical interneurons from ESCs
Within the developing forebrain, cells are identified based
on their regional, morphological, and positional characteris-
tics in combination with their gene expression patterns.
420 A.L. Goulburn et al.These attributes vary during the course of development, in-
dicating that components contributing to the identification
of a specific cell are also time dependent. However, the crit-
ical inputs of embryonic positional information are not avail-
able in an in vitro culture. Therefore, assignment of cellular
identity relies more heavily on the gene expression profile of
the cell in question, as well as aspects of its developmental
history. In the case of hESC-derived cell types, detailed
knowledge of the changes in gene expression during the gen-
esis of human neural lineages is extremely limited. As a con-
sequence, classification of such cell types is based upon the
gene expression profiles of ‘corresponding’ cells within the
developing mouse brain. This approach, however, does not
account for potential species differences in the biology of
the human and mouse forebrain development. With these
caveats in mind, Fig. 3 summarizes key genes whose expres-
sion may be utilized to classify forebrain cells generated
from differentiating ESCs.
Differentiating ESCs adopt an anterior (rostral) neural
character both in the absence of exogenous growth factor
stimulation and also upon the blockade of mesendoderm sig-
naling by exogenously added inhibitors (Elkabetz et al.,
2008; LaVaute et al., 2009; Pankratz et al., 2007; Smukler
et al., 2006; Wataya et al., 2008; Zhang et al., 2010) (forFigure 3 Key genes whose expression distinguishes forebrain line
towards an anterior neuroepithelial (NE) precursor marked by Otx
(Hoxb4, Hoxb9) is diagnostic of more posterior cell types (gray). F
with the cell surface marker Forse1 also predominantly marking eme
with Foxg1 is thought to mark ventral telencephalic cells that can g
resemble dorsal telencephalic (cortical) cells. GABA+ cells generat
cortical tissues, with Nkx2.1 expression downregulated (dotted line)
thalamus progenitors (green) capable of generating TH+ and GABA+
oligodendrocytes (orange). In this schematic, these cells are assum
because Foxg1 expression was not used to identify ESCs differentiatreviews see Gaspard and Vanderhaeghen, 2010 and Nat and
Dechant, 2011). This ESC model of neural differentiation is
consistent with the classical embryological view of neural in-
duction, whereby the first neural fate adopted is of anterior
character. This is subsequently respecified to a posterior
fate by signals emanating from more caudal domains of the
developing embryo (Gaspard and Vanderhaeghen, 2010). In-
terestingly, and in contrast to these previous ESC reports, a
study by Peljto and colleagues reported that in the absence
of any added inductive factors it was possible to generate a
subset of Hb9-expressing caudal neurons from mESCs
(Peljto et al., 2010). However, as previously mentioned, it
is important to note that differences exist between the neu-
ral commitment and differentiation of mESCs and hESCs and
it is not clear whether this result will also hold true for hESC
neural differentiation.
Studies to derive cortical interneurons have centered on
guiding ESCs toward ventral telencephalic precursors, primar-
ily defined by the co-expression of Foxg1 and Nkx2.1 (Fig. 3).
These progenitors could be further differentiated to neurons
that expressed the neurotransmitter GABA (Barberi et al.,
2003; Watanabe et al., 2005; Watanabe et al., 2007). Initial
neural induction was achieved by blocking mesendoderm for-
mation with inhibitors of Wnt, BMP or Nodal signaling. Onceages derived from differentiating ESCs. ESCs are differentiated
2, Six3 and Lhx2. Alternatively the upregulation of Hox genes
oxg1 is employed as a marker of telencephalic identity (red),
rging telencephalic precursors. Nkx2.1 expression in conjunction
enerate GABA+ neurons. Foxg1+ cells lacking Nkx2.1 expression
ed from ventral telencephalic Nkx2.1+ precursors contribute to
. Nkx2.1+Foxg1− cells are likely to represent diencephalic hypo-
neurons. Nkx2.1 cells can also give rise to telencephalic-derived
ed to derive from Foxg1+ cells, although formal proof is lacking
ing towards forebrain-derived oligodendrocytes.
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ventralized using Shh (Li et al., 2009; Watanabe et al., 2005;
Watanabe et al., 2007). Examination of the differentiated cul-
tures revealed a range of neural cell types expressing GABA,
GAD and DARPP32 (Fig. 3) (Aubry et al., 2008; Li et al., 2009;
Watanabe et al., 2005).
A number of stromal-free differentiation systems have
been described for the generation of cortical interneurons
from ESCs (Li et al., 2009; Watanabe et al., 2005;
Watanabe et al., 2007). Watanabe and colleagues described
a method to direct mESC differentiation towards telence-
phalic precursors using suspension EB cultures in serum-
free media containing specific inhibitors and growth factors
(Watanabe et al., 2005). In order to track the conversion of
mESCs to a neural fate, the group employed mESCs in
which green fluorescent protein (GFP) was inserted by ho-
mologous recombination to the locus of the early neurecto-
dermal marker, Sox1. Their study indicated that the first
5 days of differentiation were critical for achieving efficient
telencephalic differentiation (Watanabe et al., 2005). Dur-
ing this phase, mesendoderm signaling inhibitors (LeftyA
and Dkk-1) promoted the formation of telencephalic progen-
itors, as measured by the emergence of cells expressing
Foxg1 (Watanabe et al., 2005). Subsequent use of dorsalizing
(Wnt3a) and ventralizing (Shh) factors induced expression of
dorsal (Pax6) and ventral (Nkx2.1) markers respectively
within this Foxg1+ population, although the lack of a specific
tag to isolate viable Foxg1+ cells meant that it was not pos-
sible to unequivocally determine the precursor–progeny re-
lationships between cell types (Watanabe et al., 2005).
In this study, ~5–15% of the total cell population was
Foxg1+Nkx2.1+, and could therefore be nominally classified
as ventral telencephalic-like and ~5–8% of the cells were
Foxg1−Nkx2.1+, probably representing a ventral diencephal-
ic hypothalamic precursor (Watanabe et al., 2005; Wataya
et al., 2008). Although the study by Watanabe also reported
the emergence of GABA+ neurons, it was not possible to dis-
cern whether these arose from Foxg1+Nkx2.1+ (telencephal-
ic) or Foxg1−Nkx2.1+ (diencephalic) progenitors (Yee et al.,
2009). Moreover, since there are large populations of telen-
cephalic GABAergic neurons that are not of an Nkx2.1-line-
age, such as medium spiny projection neurons of the
striatum, or nearly all GABAergic interneurons of the olfac-
tory bulb, these populations may be present as well.
In order to more clearly define the emergence of ventral
telencephalic derivatives from mESCs, Maroof and col-
leagues used a transgenic Lhx6 reporter cell line to visualize
and isolate cortical interneuron precursors (Maroof et al.,
2010). A direct target of Nkx2.1 (Du et al., 2008), Lhx6 is
expressed in most MGE-derived interneurons from the time
of the cell cycle exit through postnatal maturation (Lavdas
et al., 1999; Liodis et al., 2007). Employing a GFP reporter
regulated by the Lhx6 promoter (Maroof et al., 2010), the
authors identified early subpallial derivatives in vitro
(Fig. 4A) and investigated their in vivo potential. Their dif-
ferentiation protocol used Noggin to initiate neural induc-
tion, and regionalized cell types were generated through
the application of specific factors including insulin growth
factor-1 (Igf1), Fgf2 and Shh. Transplantation experiments
showed that the Lhx6::GFP+ cells could migrate extensively
in the tangential plane, a feature of MGE-derived precursors
when compared to transplants of other forebrain regions(Wichterle et al., 2001; Wichterle et al., 2003). In addition,
they differentiate into GABA+ cortical interneurons expres-
sing subgroup markers somatostatin (SST) or parvalbumin
(PV), and displayed the corresponding SST or PV
interneuron-like electrophysiological characteristics. How-
ever, with only 2% of total cells expressing Lhx6::GFP, fur-
ther protocol optimization will be necessary in order to
generate higher yields of interneuron precursors.
In 2007, Watanabe and colleagues transferred their mESC
differentiation regimen to hESCs, using the Rho-associated
kinase (ROCK) inhibitor to reduce the apoptosis associated
with single cell dissociation of hESCs (Watanabe et al.,
2007). Neurectoderm induction was achieved by blocking
mesendoderm formation with inhibitors for BMP (BMPRIA-
Fc), WNT (DKK-1) and NODAL (LEFTYA) signaling during the
first 24 days of the differentiation (Watanabe et al., 2007).
This resulted in ~30% of total cells expressing FOXG1 at day
35, of which ~96% were PAX6+ (dorsal) and less than ~1%
were NKX2.1+ (ventral) (Watanabe et al., 2007). However,
treatment with SHH from days 24–35, increased the propor-
tion of NKX2.1+ cells to ~40% of the FOXG1+ cells (Watanabe
et al., 2007).
Li and colleagues reported that the coordination of SHH
and WNT signaling determined ventral and dorsal telence-
phalic fates in differentiating hESCs cultures (Li et al.,
2009). The protocol reported in this study included a physi-
cal separation step in which ‘definitive neuroepithelial’
cells (Li et al., 2009; Pankratz et al., 2007; Zhang et al.,
2001), marked by the appearance of neural rosette struc-
tures, were purified from surrounding non-neural cells
(Zhang et al., 2001). Similar to other studies, telencephalic
commitment was assigned on the basis of FOXG1 expression
relatively late in the differentiation program (day 31)
(Watanabe et al., 2007; Li et al., 2009). Li and colleagues
concluded that, in the absence of exogenous morphogens,
telencephalic cells from differentiating hESCs adopted a
dorsal fate primarily through activation of the WNT signaling
pathway and its impact on the ratio of the GLI3 activator/re-
pressor isoforms (Li et al., 2009). This conclusion was sup-
ported by the finding that inhibiting WNT signaling, or
addition of SHH, could result in ~85% of the total population
expressing NKX2.1 (Li et al., 2009). End-stage GABA+ cells
were generated in these differentiating cultures, however
as with the study performed by Watanabe, whether these
GABA+ neurons were derived from FOXG1+NKX2.1+ precur-
sors could not be determined. To further highlight this
point, Maroof et al., noted widespread expression of GABA
throughout their differentiation cultures, demonstrating
that while all Lhx6::GFP+ cells were GABA+, not all GABA+
cells were LHX6::GFP+. They concluded that GABA expres-
sion alone could not be used as a definitive marker of ventral
telencephalic-derived cortical interneurons (Maroof et al.,
2010).
In the ESC studies described above, two general princi-
ples are apparent. First, neural differentiation was achieved
through inhibition of mesendoderm induction pathways, im-
plying that, within each culture system, endogenous mesen-
doderm promoting signals were present that required
inhibition. Second, after neural induction, the ‘naïve’ neural
progenitors were patterned using a second round of treat-
ment with dorsalizing factors such as Wnt3a or ventralizing
factors including Shh.
Figure 4 Genetically engineered reporter lines assist in the identification of telencephalic cells differentiated from ESCs.
(A) Maroof et al., demonstrated the ability to track in vitro the onset of Lhx6 expression within a mixed neural culture
using a transgenic Lhx6::GFP mESC line. (B) Goulburn et al., reported the generation of a human ESC line in which GFP
was inserted into the NKX2.1 locus using homologous recombination. This line was used to isolate and further differentiate
NKX2.1 expressing cells, and subsequently demonstrate a precursor-progeny relationship between hESC derived NKX2.1+ progenitors
and GAD (GABA) expressing neurons in vitro.
422 A.L. Goulburn et al.We have recently reported the generation of an
NKX2.1GFP/w targeted hESC line using homologous recombi-
nation (Goulburn et al., 2011). Using the reporter line, we
showed the emergence of NKX2.1-GFP+ ventral forebrain
progenitors within differentiating ‘spin EB’ cultures using a
serum-free defined medium (Fig. 4B) (Ng et al., 2008a; Ng
et al., 2008b). Neural induction was achieved without the
use of exogenous mesendoderm signaling inhibitors but rath-
er by the combinatorial application of FGF2 and retinoic acid
(RA) (Goulburn et al., 2011). Cultures consistently generated
5–15% NKX2.1-GFP+ cells, with GFP+ precursors emerging by
day 14 of the differentiation. While the use of RA in the der-
ivation of anterior neural cell types is contentious, there is
evidence to support its role in ventral telencephalic pattern-
ing (Bissonnette et al., 2011; Schneider et al., 2001), and in
forebrain GABAergic differentiation (Chatzi et al., 2011).
The results in our study demonstrated both a time and con-
centration dependent requirement for RA in generating
NKX2.1-GFP+ cells, consistent with previous telencephalic
ESC studies (Li et al., 2009; Watanabe et al., 2005). For ex-
ample, Watanabe demonstrated that early treatment of
mESCs (day 3–10) with RA had a caudalizing effect on cul-
tures, whereas later treatment (day 6–10) did not
(Watanabe et al., 2005). At these later treatment times, ex-
pression of anterior markers, Otx2 and Foxg1 persisted even
with RA application (Watanabe et al., 2005). Likewise, Li
and colleagues showed that RA treatment of neurally com-
mitted differentiating hESCs at day 17 had little effect and
did not appear to induce expression of caudal genes nor re-
sult in the inhibition of FOXG1 expression (Li et al., 2005;
Li et al., 2009). Nevertheless, it would be interesting to
compare the transcriptional profiles and developmentalpotentials of human NKX2.1-GFP+ precursors generated
using the multiple published protocols, especially given
that there may be additional domains of NKX2.1 expression
within the human forebrain. For example, although pallidal
expression of NKX2.1 appears to be similar during mouse
and human development, NKX2.1 is also strongly expressed
in the human fetal cortex, in the proliferative zone, cortical
plate and layer I (Fertuzinhos et al., 2009; Rakic and
Zecevic, 2003; Zecevic et al., 2005).
The NKX2.1GFP/w hESC line enabled us to isolate viable
NKX2.1-expressing cells, allowing the unequivocal identifi-
cation of their progeny. NKX2.1-GFP+ cells generated
GABA+ cells both in vitro and in vivo (Fig. 4B), and a small
proportion of cells expressed somatostatin (SST), a marker
of more mature cortical interneurons. Interestingly,
NKX2.1-GFP+ progenitors also generated tyrosine hydroxy-
lase (TH+) cells indicating a potentially mixed telencephal-
ic/diencephalic nature of the precursor population,
although TH+ GABAergic interneurons are also present in pri-
mate neocortex. While Watanabe and colleagues reported in
their mESC study that approximately half of the counted
Nkx2.1 population was Foxg1−, our results showed that the
RA-induced NKX2.1-GFP+ cells emerged as FOXG1−, before
upregulating the transcription factor during extended cul-
ture of the harvested cells (Goulburn et al., 2011;
Watanabe et al., 2005).
Recently, Danjo and colleagues have demonstrated ven-
tral telencephalic subregional specification of mESCs by
employing patterning factors in a temporal and combinatori-
al manner (Danjo et al., 2011). Using a Foxg1::Venus knock-
in mESCs (Watanabe et al., 2005), their study demonstrated
that low concentrations of the morphogen Shh at early
423Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cellstime-points of addition generated telencephalic LGE cell de-
rivatives. These LGE cell types could differentiate into ma-
ture medium-sized spiny striatal neurons both in vivo and
in vitro (Danjo et al., 2011). In contrast, high concentrations
of Shh or the Hedgehog agonist SAG at later time-points gen-
erated MGE and CGE cell subtypes (Danjo et al., 2011). Use
of different FGF growth factors post Shh application was
shown to alter the balance between MGE- and CGE-derived
cortical interneuron subgroups (Danjo et al., 2011). The
study also highlighted the importance of transplanting pure
populations of differentiated cells in order to prevent
tumor formation.
The results of this study mirror the effects of Shh in
mouse forebrain development (Rallu et al., 2002b),
highlighting the profound effects that small increments in
growth factor concentration may have on the generation of
distinct telencephalic cell populations from which cortical
interneurons are derived in a mESC setting. It will also be in-
teresting to examine whether similar results hold true when
applied to hESC differentiation regimes.
Therapeutic applications of
cortical interneurons
Cortical GABAergic interneuron precursors have the remark-
able ability to migrate extensively and survive after trans-
plantation into the postnatal cortex, making these cells an
attractive candidate for use in cell-based therapy for sei-
zures or other neuropsychiatric illnesses (Maroof et al.,
2010). Several recent studies have highlighted the potential
therapeutic benefits of embryonic MGE-derived precursors
and the inhibitory interneurons that they generate.
Martinez-Cerdeno and colleagues reported on the poten-
tial benefits of using embryonic MGE precursors for Parkin-
son's disease (Martinez-Cerdeno et al., 2010). In their
study, E14.5 MGE precursors were transplanted into the stri-
atum in a rat Parkinson's disease model (6-hydroxydopamine
(6-OHDA)) with results demonstrating that the transplanted
MGE cells integrated into the host circuitry and improved
motor symptoms (Martinez-Cerdeno et al., 2010). Similarly,
Baraban and colleagues utilized embryonic MGE precursors
as potential treatments for epilepsy (Baraban et al., 2009).
By grafting MGE precursor cells into the postnatal neocortex
in a mouse model of epilepsy, Baraban and colleagues dem-
onstrated an increase in GABA-mediated synaptic and extra-
synaptic inhibition and a significant reduction in the
frequency and duration of seizures (Baraban et al., 2009).
Furthermore, other laboratories have demonstrated reduced
seizure frequency following transplantation of MGE-derived
cells into the cortex in various rodent models of epilepsy
(Calcagnotto et al., 2010a,b; De la Cruz et al., 2011;
Waldau et al., 2010; Zipancic et al., 2010). While these stud-
ies are preliminary, it is tantalizing to think that MGE precur-
sors may be used as a cell therapy for a variety neurological
and neurodevelopmental disorders. Therefore, generating
sufficient MGE-like precursors from ESCs for transplantation,
and thereby overcoming the limitations associated with tis-
sue donation, could be of enormous benefit. However, with
ESC-derived cortical interneuron research in its infancy, a
more careful analysis is needed to better define and charac-
terize the MGE-like progenitors. For example improvementsin protocols to yield greater frequencies of precursor cells
and long-term transplantation experiments to examine neu-
ronal survival, migration and maturation need to be per-
formed. That Maroof et al., could detect mES derived
interneurons in mouse neocortex transplants 6 months fol-
lowing neonatal transplantation, bodes well for the poten-
tial therapeutic value of this system.
The generation of ESC-derived MGE precursors also pro-
vides an opportunity to analyze homogenous populations of
human inhibitory interneurons. Growth factors and com-
pounds can be assayed to determine their capacity to prefer-
entially direct interneuron subtypes, offering important
insights into early human forebrain interneuron fate deter-
mination (McKernan et al., 2010). Compound libraries can
be used to screen for agents that influence neuronal firing
or inhibition, enhance synaptic functioning, or impact upon
survival and proliferation of cortical interneurons. Such
screens could lead to the identification of new cortical
interneuron-associated therapeutics.
Although not discussed in detail in this review, the emer-
gence of iPSC technology will now permit the modeling of
neuropsychiatric diseases in vitro (Cundiff and Anderson,
2011). For instance, mutations to the X-linked Aristaless re-
lated homeobox (Arx) gene have been implicated in improp-
er migration of GABAergic interneurons from the subpallium
proliferative zones to the cortex, potentially resulting in au-
tism and epilepsy (Friocourt and Parnavelas, 2010). Similar-
ly, a translocation involving the gene Disrupted in
Schizophrenia-1 (DISC1), which appears to be crucial for in-
tracellular mechanisms associated with neurite outgrowth,
identifies this locus as a candidate involved in the genesis
of schizophrenia (Kamiya et al., 2005; Pletnikov et al.,
2008). Derivation of disease cell lines (for example see
Brennand et al., 2011) from patients carrying such candidate
gene mutations has the potential to result in greater under-
standing of disease etiology as well as enabling exploration
of downstream signaling targets, resulting in the possible de-
velopment of new therapeutics.Conclusion
Dysfunction of GABAergic interneurons of the cerebral cor-
tex has been implicated in a variety of major neuropsychiat-
ric illnesses, including schizophrenia, autism, anxiety, and
epilepsy. However, both our imperfect knowledge of the de-
velopment and function of human cortical interneurons, and
our lack of understanding of the manner in which disease re-
lated genes may influence these processes, hinder our abili-
ty to understand, prevent or treat interneuron-related
mental illness. HESCs represent an important source of
human interneurons that could be used to map normal devel-
opment, to explore genetic influences on interneuron devel-
opment and function, and to study genetic–environmental
interactions in forebrain development. ESCs, therefore,
have great potential to enhance our understanding the mo-
lecular basis of neuropsychiatric illnesses and for the devel-
opment of novel preventions and treatments, including cell
therapies.
Despite the tremendous potential of ESCs for understand-
ing interneuron-related disease, major challenges remain to
be solved before this promise can be realized. For example,
424 A.L. Goulburn et al.since distinct interneuron subtypes are differentially affect-
ed in various disorders (Lewis et al., 2011; Sibille et al.,
2011), how will we generate these subtypes from human
stem cells? Since key aspects of interneuron function depend
not only on the presence of class-defining markers, but also
on specific patterns of inputs, intrinsic activity, and axonal
targeting onto other neurons, what assays will allow us to
study these features? Second, how do we differentiate ESCs
into distinct interneuron types, and what system can we
use to define these subtypes outside of the human brain?
The studies reviewed in this manuscript relating to human
GABAergic interneurons differentiated from ESCs comple-
ment limited human embryological data. With most prior
models for human forebrain specification based on the
mouse, more recent investigations now serve to highlight
both the similarities and disparities between mammalian
species and remind us of the complexity of human prosence-
phalic development. We are confident that the ongoing
studies of human ESC neural differentiation will result in
continuing progress in unraveling the complexities of
human cortical interneuron development.
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